2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association

SS Martin, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Heart disease and stroke statistics—2022 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, A Alonso… - Circulation, 2022 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Heart disease and stroke statistics—2023 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Heart disease and stroke statistics—2020 update: a report from the American Heart Association

SS Virani, A Alonso, EJ Benjamin, MS Bittencourt… - Circulation, 2020 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports on the most up-to-date statistics related to heart disease, stroke …

[HTML][HTML] Heart disease and stroke statistics-2021 update: a report from the American Heart Association.

SS Virani, A Alonso, HJ Aparicio, EJ Benjamin… - 2021 - dukespace.lib.duke.edu
Background The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient …

Y Wang, J Jing, X Meng, Y Pan, Y Wang… - Stroke and vascular …, 2019 - svn.bmj.com
Background and purpose Stroke is the leading cause of mortality and disability in China.
Precise aetiological classification, imaging and biological markers may predict the prognosis …

[HTML][HTML] Effects of semaglutide on stroke subtypes in type 2 diabetes: post hoc analysis of the randomized SUSTAIN 6 and PIONEER 6

WD Strain, O Frenkel, MA James, LA Leiter… - Stroke, 2022 - journals.lww.com
Background: GLP-1 RA (glucagon-like peptide-1 receptor agonists), including semaglutide,
may reduce stroke risk in people with type 2 diabetes. This post hoc analysis examined the …

Machine learning to predict mortality after rehabilitation among patients with severe stroke

D Scrutinio, C Ricciardi, L Donisi, E Losavio… - Scientific reports, 2020 - nature.com
Stroke is among the leading causes of death and disability worldwide. Approximately 20–
25% of stroke survivors present severe disability, which is associated with increased …

Benefits of GLP-1 (glucagon-like peptide 1) receptor agonists for stroke reduction in type 2 diabetes: a call to action for neurologists

RM Goldenberg, AYY Cheng, T Fitzpatrick, JD Gilbert… - Stroke, 2022 - Am Heart Assoc
People living with diabetes are at higher risk for stroke and have a poorer prognosis
following a stroke event than those without diabetes. Data from cardiovascular outcome …

Long-term survival, stroke recurrence, and life expectancy after an acute stroke in Australia and New Zealand from 2008–2017: a population-wide cohort study

Y Peng, L Ngo, K Hay, A Alghamry, K Colebourne… - Stroke, 2022 - Am Heart Assoc
Background: Data on long-term outcomes following an acute stroke are sparse. We
assessed survival, risk of recurrent stroke and loss in life expectancy following an acute …